Single Cell Sequencing of Tonsillar Tissue in Children With OSA

Recruiting Observational Study
Obstructive Sleep Apnea of Child
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 – 11
Sex
Any
Study type
Observational
Participants needed
15 (estimated)
Sponsor
Chinese University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Obstructive sleep apnoea (OSA) in children is a prevalent sleep disorder, and is characterised by repetitive complete or partial upper airway obstruction during sleep. It is an important disease as it is associated with a large spectrum of end-organ morbidities. Adenotonsillar hypertrophy is the commonest cause of OSA in children, however, the cause of the lymphoid tissue hypertrophy in some indi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Case: Chinese children aged 6-11 years old with habitual snoring (≥3 nights per week) and polysomnography (PSG) confirmed OSA (obstructive apnoea hypopnoea index (OAHI) of ≥1/hour), with adenotonsillar hypertrophy and clinical indications for adenotonsillectomy will be recruited…
Contacts

Kate C Chan, MBChB

35052840

katechan@cuhk.edu.hk

CONTACT

Elly Cheung

35052840

ellycheung@cuhk.edu.hk

CONTACT